Author

Christina J. Meisl

Observed names: C.M. Meisl, Christina Meisl

Institutions: Spital Thurgau (Switzerland), Kantonsspital Frauenfeld

Observed institutions: Humboldt-Universität zu Berlin, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Spital Thurgau (Switzerland), Kantonsspital Frauenfeld, Freie Universität Berlin, Charité – Universitätsmedizin Berlin

ORCID: 0000-0003-1657-0086

Observed ORCID: 0000-0003-1657-0086

OpenAlex ID: A5070199190

BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study

2023 · Thorsten H. Ecke, Christina J. Meisl, et al. · Urologic Oncology Seminars and Original Investigations · 31

Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, CancerCheck UBC Rapid VISUAL, and Uromonitor in Comparison to Cytology

2024 · Thorsten H. Ecke, Christina J. Meisl, et al. · Urology · 11

Nomograms including the UBC ® Rapid test to detect primary bladder cancer based on a multicentre dataset

2021 · Christina J. Meisl, Pierre I. Karakiewicz, et al. · British Journal of Urology · 9

Digital PCR-Based Uromonitor for Molecular Detection of Bladder Cancer: A Multicenter Validation Study Comparing Quantitative PCR and Urine Cytology

2026 · Anton Kravchuk, Julio Ruben Rodas Garzaro, et al. · Clinical Genitourinary Cancer · 4

Lessons learned from our preliminary experience with MiLEP: a retrospective analysis of efficacy and safety using slim and ultra-slim instruments

2025 · Patrick Rein, Christina Meisl, et al. · World Journal of Urology · 4

Design and Testing of a Novel Transcranial Magnetic Stimulator with Adjustable Pulse Dynamics and High Current Capability (>2 kA) based on a Modular Cascaded H-Bridge Inverter Topology

2021 · Florian Schwitzgebel, Manuel Kuder, et al. · Chalmers Research (Chalmers University of Technology) · 4

Comparison of efficacy of ultraslim (18.5 Fr) versus slim (22 Fr) HoLEP: A propensity-matched analysis

2025 · P. Rein, C.M. Meisl, et al. · European Urology Open Science

First experience with slim (22 Fr) vs. ultra slim (18.5 Fr) HoLEP in prostates ≤60 ccm: Is there any disadvantage to using the ultra slim 18.5 Fr HoLEP system?

2025 · P. Rein, C.M. Meisl, et al. · European Urology Open Science

Mp61-08 Trop-2—a Promising New Therapeutic Target in Penile Squamous Cell Carcinoma

2024 · Richard Weiten, Carolina Kessler, et al. · The Journal of Urology

Works count: 9

Citation count: 63

H-index: 4

I10-index: 2